Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability. Now, researchers have successfully modified MSCs to deliver large quantities of anti-cancer drugs in a targeted manner to developing cancer cells.
Stem Cells therapy
European Clinical Trials Information Network
European Clinical Trials Information Network The European Clinical Trials Information Network revolutionizes how patients across Europe access clinical trial information. By eliminating language barriers, our platform ensures that everyone, regardless of their native language, can Read more…